Compendium of Cancer Genome Aberrations

Changes

ENDO5:Volunteer Assignments and Opportunities (view source)

Revision as of 11:21, 26 February 2024

11,800 bytes added ,  26 February
no edit summary
Line 17: Line 17:  
!'''Notes'''
 
!'''Notes'''
 
|-
 
|-
 +
|CHAPTER 2 (PITUITARY TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[ENDO5:Somatotroph_PitNET/adenoma|Somatotroph PitNET/adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Mammosomatotroph_PitNET/adenoma|Mammosomatotroph PitNET/adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Lactotroph_PitNET/adenoma|Lactotroph PitNET/adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Thyrotroph_PitNET/adenoma|Thyrotroph PitNET/adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Mature_plurihormonal_PIT1-lineage_PitNET/adenoma|Mature plurihormonal PIT1-lineage PitNET/adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 27: Line 92:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Immature_PIT1-lineage_PitNET/adenoma|Immature PIT1-lineage PitNET/adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 36: Line 103:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Acidophil_stem_cell_PitNET/adenoma|Acidophil stem cell PitNET/adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 45: Line 114:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Mixed_somatotroph-lactotroph_PitNET/adenoma|Mixed somatotroph-lactotroph PitNET/adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 54: Line 125:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Corticotroph_PitNET/adenoma|Corticotroph PitNET/adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 63: Line 136:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Gonadotroph_PitNET/adenoma|Gonadotroph PitNET/adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 72: Line 147:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Null_cell_PitNET/adenoma|Null cell PitNET/adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 81: Line 158:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Plurihormonal_PitNET/adenomas|Plurihormonal PitNET/adenomas]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 90: Line 169:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Multiple_synchronous_PitNET/adenomas_of_distinct_lineages|Multiple synchronous PitNET/adenomas of distinct lineages]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 99: Line 180:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Metastatic_PitNET|Metastatic PitNET]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 108: Line 191:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adamantinomatous_craniopharyngioma|Adamantinomatous craniopharyngioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 117: Line 202:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Papillary_craniopharyngioma|Papillary craniopharyngioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 126: Line 213:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Pituitary_blastoma|Pituitary blastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 135: Line 224:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Pituicytomas|Pituicytomas]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 144: Line 235:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Gangliocytoma_and_mixed_gangliocytoma-PitNET/adenoma|Gangliocytoma and mixed gangliocytoma-PitNET/adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Sellar_neurocytoma|Sellar neurocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Meningiomas|Meningiomas]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 153: Line 268:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Chordoma|Chordoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 162: Line 279:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|CHAPTER 3 (THYROID TUMOURS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Thyroglossal_duct_cyst|Thyroglossal duct cyst]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 180: Line 310:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Other_congenital_thyroid_abnormalities|Other congenital thyroid abnormalities]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 189: Line 321:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Thyroid_follicular_nodular_disease|Thyroid follicular nodular disease]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 198: Line 332:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Follicular_thyroid_adenoma|Follicular thyroid adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 207: Line 343:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Follicular_thyroid_adenoma_with_papillary_architecture|Follicular thyroid adenoma with papillary architecture]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 216: Line 354:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Oncocytic_adenoma_of_the_thyroid|Oncocytic adenoma of the thyroid]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 225: Line 365:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Non-invasive_follicular_thyroid_neoplasm_with_papillary-like_nuclear_features|Non-invasive follicular thyroid neoplasm with papillary-like nuclear features]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 234: Line 376:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Thyroid_tumours_of_uncertain_malignant_potential|Thyroid tumours of uncertain malignant potential]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 243: Line 387:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Hyalinizing_trabecular_tumour|Hyalinizing trabecular tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 252: Line 398:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Follicular_thyroid_carcinoma|Follicular thyroid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 261: Line 409:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Invasive_encapsulated_follicular_variant_of_papillary_thyroid_carcinoma|Invasive encapsulated follicular variant of papillary thyroid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 270: Line 420:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Papillary_thyroid_carcinoma|Papillary thyroid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 279: Line 431:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Oncocytic_carcinoma_of_the_thyroid|Oncocytic carcinoma of the thyroid]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 288: Line 442:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:High-grade_follicular_cell-derived_non-anaplastic_thyroid_carcinoma|High-grade follicular cell-derived non-anaplastic thyroid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 297: Line 453:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Anaplastic_thyroid_carcinoma|Anaplastic thyroid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 306: Line 464:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Medullary_thyroid_carcinoma|Medullary thyroid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 315: Line 475:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Mixed_medullary_and_follicular_cell-derived_thyroid_carcinomas|Mixed medullary and follicular cell-derived thyroid carcinomas]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 324: Line 486:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Mucoepidermoid_carcinoma|Mucoepidermoid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 333: Line 497:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Secretory_carcinoma|Secretory carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 342: Line 508:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Sclerosing_mucoepidermoid_carcinoma_with_eosinophilia|Sclerosing mucoepidermoid carcinoma with eosinophilia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 351: Line 519:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Cribriform_morular_thyroid_carcinoma|Cribriform morular thyroid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 360: Line 530:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Thymoma|Thymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 369: Line 541:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Spindle_epithelial_tumour_with_thymus-like_elements|Spindle epithelial tumour with thymus-like elements]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 378: Line 552:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Intrathyroidal_thymic_carcinoma|Intrathyroidal thymic carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 387: Line 563:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Thyroblastoma|Thyroblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 396: Line 574:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|CHAPTER 4 (PARATHYROID TUMOURS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Parathyroid_hyperplasia|Parathyroid hyperplasia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 414: Line 605:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Parathyroid_adenoma|Parathyroid adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 423: Line 616:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Parathyroid_lipoadenoma|Parathyroid lipoadenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 432: Line 627:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Atypical_parathyroid_tumour|Atypical parathyroid tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 441: Line 638:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Parathyroid_carcinoma|Parathyroid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 450: Line 649:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|CHAPTER 5 (ADRENAL GLAND TUMOURS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adrenal_rests|Adrenal rests]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 468: Line 680:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adrenal_cysts|Adrenal cysts]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 477: Line 691:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adrenal_myelolipoma|Adrenal myelolipoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 486: Line 702:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Congenital_adrenal_hyperplasia|Congenital adrenal hyperplasia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 495: Line 713:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adrenocortical_nodular_disease|Adrenocortical nodular disease]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 504: Line 724:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adrenal_cortical_adenoma|Adrenal cortical adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 513: Line 735:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adrenal_cortical_carcinoma|Adrenal cortical carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 522: Line 746:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adrenal_sex_cord_stromal_tumour|Adrenal sex cord stromal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 531: Line 757:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adenomatoid_tumour|Adenomatoid tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 540: Line 768:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adrenal_melanoma|Adrenal melanoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 549: Line 779:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|CHAPTER 6 (ADRENAL MEDULLA AND EXTRA-ADRENAL PARAGANGLIA TUMOURS)
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Neuroblastoma|Neuroblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 567: Line 810:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Ganglioneuroblastoma,_intermixed|Ganglioneuroblastoma, intermixed]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 576: Line 821:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Ganglioneuroblastoma,_nodular|Ganglioneuroblastoma, nodular]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 585: Line 832:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Ganglioneuroma|Ganglioneuroma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 594: Line 843:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Phaeochromocytoma|Phaeochromocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 603: Line 854:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Sympathetic_paraganglioma|Sympathetic paraganglioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 612: Line 865:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Parasympathetic_paraganglioma|Parasympathetic paraganglioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 621: Line 876:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Composite_phaeochromocytomas_and_paragangliomas|Composite phaeochromocytomas and paragangliomas]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 630: Line 887:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|CHAPTER 7 (PANCREATIC NEUROENDOCRINE NEOPLASMS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Non-functioning_(non-syndromic)_pancreatic_neuroendocrine_tumours|Non-functioning (non-syndromic) pancreatic neuroendocrine tumours]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 648: Line 918:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Insulinoma|Insulinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 657: Line 929:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Glucagonoma|Glucagonoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 666: Line 940:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Somatostatinoma|Somatostatinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 675: Line 951:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Gastrinoma|Gastrinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 684: Line 962:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:VIPoma|VIPoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 693: Line 973:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Serotonin-producing_tumours_with_and_without_carcinoid_syndrome|Serotonin-producing tumours with and without carcinoid syndrome]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 702: Line 984:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Other_pancreatic_neuroendocrine_tumours_with_ectopic_hormone_production|Other pancreatic neuroendocrine tumours with ectopic hormone production]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 711: Line 995:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Pancreatic_neuroendocrine_carcinoma|Pancreatic neuroendocrine carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 720: Line 1,006:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Mixed_ductal_adenocarcinoma-neuroendocrine_neoplasms|Mixed ductal adenocarcinoma-neuroendocrine neoplasms]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 729: Line 1,017:  
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Mixed_acinar-neuroendocrine_carcinoma|Mixed acinar-neuroendocrine carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 738: Line 1,028:  
|
 
|
 
|-
 
|-
 +
|CHAPTER 8 (NEUROENDOCRINE NEOPLASMS IN NON-ENDOCRINE ORGANS)
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[ENDO5:Neuroendocrine_tumours|Neuroendocrine tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Small_cell_neuroendocrine_carcinoma|Small cell neuroendocrine carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Large_cell_neuroendocrine_carcinoma|Large cell neuroendocrine carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Merkel_cell_carcinoma|Merkel cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Mixed_neuroendocrine-non-neuroendocrine_neoplasms|Mixed neuroendocrine-non-neuroendocrine neoplasms]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Composite_gangliocytoma/neuroma_and_neuroendocrine_tumour|Composite gangliocytoma/neuroma and neuroendocrine tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Cauda_equina_neuroendocrine_tumour_(previously_paraganglioma)|Cauda equina neuroendocrine tumour (previously paraganglioma)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 9 (MESENCHYMAL AND STROMAL TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[ENDO5:Lipoma|Lipoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Benign_vascular_tumours|Benign vascular tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:PEComa|PEComa]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Glomangioma_and_glomus_tumour|Glomangioma and glomus tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Angiosarcoma|Angiosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Leiomyoma|Leiomyoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Leiomyosarcoma|Leiomyosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Rhabdomyosarcomas|Rhabdomyosarcomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Schwannoma|Schwannoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Neurofibroma|Neurofibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Granular_cell_tumour|Granular cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 10 (HAEMATOLYMPHOID TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[ENDO5:IgG4-related_disease|IgG4-related disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Extranodal_marginal_zone_lymphoma|Extranodal marginal zone lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Diffuse_large_B-cell_lymphoma|Diffuse large B-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Erdheim-Chester_disease|Erdheim-Chester disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Follicular_dendritic_cell_sarcoma|Follicular dendritic cell sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 11 (GERM CELL TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[ENDO5:Germ_cell_tumours_in_endocrine_organs|Germ cell tumours in endocrine organs]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Teratomas_with_endocrine_differentiation|Teratomas with endocrine differentiation]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 12 (METASTASIS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[ENDO5:Metastasis_to_the_pituitary_gland|Metastasis to the pituitary gland]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Metastasis_to_the_thyroid_gland|Metastasis to the thyroid gland]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Metastasis_to_the_adrenal_gland|Metastasis to the adrenal gland]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 13 (GENETIC TUMOUR SYNDROMES ASSOCIATED WITH ENDOCRINE LESIONS AND TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[ENDO5:Multiple_endocrine_neoplasia_type_1|Multiple endocrine neoplasia type 1]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Multiple_endocrine_neoplasia_type_2|Multiple endocrine neoplasia type 2]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Multiple_endocrine_neoplasia_type_4|Multiple endocrine neoplasia type 4]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Multiple_endocrine_neoplasia_type_5_(MAX-related_tumours)|Multiple endocrine neoplasia type 5 (MAX-related tumours)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Hyperparathyroidism-jaw_tumour_syndrome|Hyperparathyroidism-jaw tumour syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:SDH-deficient_tumour_syndromes|SDH-deficient tumour syndromes]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Carney_complex|Carney complex]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:McCune-Albright_syndrome|McCune-Albright syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:DICER1_syndrome|DICER1 syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Glucagon_cell_hyperplasia_and_neoplasia|Glucagon cell hyperplasia and neoplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:MAFA-related_familial_insulinomatosis|MAFA-related familial insulinomatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Syndromic_familial_follicular_cell-derived_thyroid_tumours|Syndromic familial follicular cell-derived thyroid tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Non-syndromic_familial_follicular_cell-derived_thyroid_tumours|Non-syndromic familial follicular cell-derived thyroid tumours]]
 
|Disease
 
|Disease
 
|
 
|
Retrieved from "https://ccga.io/index.php/Special:MobileDiff/14037...14260"